Jove
Visualize
Contact Us

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cobimetinib and Irinotecan Liposome.

Hospital pharmacy·2024
Same author

Pertuzumab, Trastuzumab, and Docetaxel for HER2-Positive Breast Cancer.

Hospital pharmacy·2024
Same author

Drug Monographs: Trabectedin and Trifluridine-Tipiracil.

Hospital pharmacy·2024
Same author

Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases.

Hospital pharmacy·2017
Same author

Drug Monographs: Avelumab and Ribociclib.

Hospital pharmacy·2017
Same author

Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.

Hospital pharmacy·2017
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 1, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K

Blinatumomab and Pembrolizumab.

Emily E Tabor1, J Aubrey Waddell1, Dominic A Solimando1

  • 1Dr. Tabor is a Pharmacy Practice (PGY1) Resident at Blount Memorial Hospital , Maryville, Tennessee.

Hospital Pharmacy
|October 9, 2015
PubMed
Summary
This summary is machine-generated.

This review covers essential aspects of cancer chemotherapy for pharmacists, including drug preparation, dispensing, and administration of antineoplastic therapy and agents.

More Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

11.2K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.7K

Related Experiment Videos

Last Updated: Apr 1, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

11.2K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.7K

Area of Science:

  • Oncology Pharmacy
  • Chemotherapy Administration

Background:

  • Cancer chemotherapy involves complex regimens and toxic agents.
  • Pharmacists require specialized knowledge for safe and effective patient care.

Purpose of the Study:

  • To review key issues in the preparation, dispensing, and administration of antineoplastic therapy.
  • To discuss commercially available and investigational agents used in treating malignant diseases.

Main Methods:

  • Literature review and expert synthesis of current practices in oncology pharmacy.
  • Discussion of challenges and best practices in managing chemotherapy.

Main Results:

  • Identified critical areas for pharmacist involvement in chemotherapy.
  • Highlighted the importance of understanding both established and novel antineoplastic agents.

Conclusions:

  • Pharmacists play a vital role in optimizing cancer chemotherapy outcomes.
  • Continuous education on chemotherapy agents and protocols is essential for oncology pharmacists.